Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synbio TechROCO:1295 -0.40%44 PB Ratio is 1.31 as of Jul. 17, 2026, which is 44% below its 10-year median of 2.36. GuruFocus rates ROCO:1295 with a GF Score™ of 44/100. The stock has 10 warning signs investors should review. Among 1,227 Biotechnology companies, Synbio Tech ranks better than 75.63% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-17), Synbio Tech's share price is NT$50.40. Synbio Tech's Book Value per Share for the quarter that ended in Dec. 2025 was NT$38.47. Hence, Synbio Tech's PB Ratio of today is 1.31.
Good Sign:
Synbio Tech Inc stock PB Ratio (=1.28) is close to 3-year low of 1.22.
The historical rank and industry rank for Synbio Tech's PB Ratio or its related term are showing as below:
ROCO:1295'
s PB Ratio Range Over the Past 10 Years
Min: 1.22 Med: 2.36 Max: 4.4
Current: 1.3
During the past 6 years, Synbio Tech's highest PB Ratio was 4.40. The lowest was 1.22. And the median was 2.36.
ROCO:1295's PB Ratio is ranked better than 75.63% of 1227
companies
in the Biotechnology industry
Industry Median: 2.82
vs ROCO:1295: 1.30
During the past 12 months, Synbio Tech's average Book Value Per Share Growth Rate was 12.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 10.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 9.10% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Synbio Tech was 10.50% per year. The lowest was 7.50% per year. And the median was 7.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Synbio Tech PB Ratio Related Terms
Synbio Tech PB Ratio Historical Data
* Premium members only.
The historical data trend for Synbio Tech's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: PB Ratio Comparison
For the Biotechnology subindustry, Synbio Tech's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's PB Ratio distribution charts can be found below:
* The bar in red indicates where Synbio Tech's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Synbio Tech's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Synbio Tech (ROCO:1295) has a PB Ratio of 1.31 as of Jul. 17, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Synbio Tech and its competitors. This is 44% below median its historical median of 2.36. Over the past decade, Synbio Tech's PB Ratio has ranged from 1.22 to 4.40. According to the industry distribution chart, Synbio Tech ranks #299 out of 1227 companies in the Biotechnology industry, placing it in the top 24.4%.
Is Synbio Tech's PB Ratio too high?
Synbio Tech's current PB Ratio of 1.31 is 44% below median its 10-year median of 2.36. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 4.40. The Biotechnology industry median PB Ratio is 2.82. Synbio Tech's value of 1.31 is 53.5% below this industry median. Based on the distribution chart, Synbio Tech ranks #299 out of 1227 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synbio Tech ranks #299 out of 1227 companies for PB Ratio. This places Synbio Tech in the top 24% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.82. Synbio Tech's value of 1.31 is 53.5% below this benchmark. Historically, Synbio Tech's own PB Ratio has ranged from 1.22 to 4.40 over the past decade. While the company's 10-year median is 2.36 vs. the industry median of 2.82, Synbio Tech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.82, based on 1,227 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synbio Tech's current PB Ratio of 1.31 is 53.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Synbio Tech and its competitors. For the Biotechnology industry, the median PB Ratio is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synbio Tech's current PB Ratio is 1.31, which is 44% below median its own 10-year median of 2.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current PB Ratio of 1.31. The current PB Ratio is 1.31, which is 44% below median its 10-year median of 2.36 and 53.5% below the Biotechnology industry median of 2.82. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current PB Ratio is 1.31 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
